KOVO+ HOLDINGS INC (KOVO.CA) Stock Fundamental Analysis

TSX-V:KOVO • CA5007421012

0.025 CAD
0 (0%)
Last: Feb 18, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

1

Taking everything into account, KOVO scores 1 out of 10 in our fundamental rating. KOVO was compared to 9 industry peers in the Health Care Technology industry. KOVO has a bad profitability rating. Also its financial health evaluation is rather negative. KOVO is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • KOVO had negative earnings in the past year.
  • In the past year KOVO has reported a negative cash flow from operations.
KOVO.CA Yearly Net Income VS EBIT VS OCF VS FCFKOVO.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 -1M -2M -3M -4M -5M

1.2 Ratios

  • KOVO has a Return On Assets of -43.18%. This is in the better half of the industry: KOVO outperforms 66.67% of its industry peers.
Industry RankSector Rank
ROA -43.18%
ROE N/A
ROIC N/A
ROA(3y)-35.27%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
KOVO.CA Yearly ROA, ROE, ROICKOVO.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 500 1K 1.5K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for KOVO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
KOVO.CA Yearly Profit, Operating, Gross MarginsKOVO.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 -10 -20 -30 -40 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. Health

2.1 Basic Checks

  • KOVO does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • KOVO has more shares outstanding than it did 1 year ago.
  • KOVO has a worse debt/assets ratio than last year.
KOVO.CA Yearly Shares OutstandingKOVO.CA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 20M 40M 60M 80M 100M
KOVO.CA Yearly Total Debt VS Total AssetsKOVO.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

  • KOVO has an Altman-Z score of -3.20. This is a bad value and indicates that KOVO is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of -3.20, KOVO perfoms like the industry average, outperforming 44.44% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -3.2
ROIC/WACCN/A
WACC6.15%
KOVO.CA Yearly LT Debt VS Equity VS FCFKOVO.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 2M -2M 4M -4M

2.3 Liquidity

  • A Current Ratio of 0.07 indicates that KOVO may have some problems paying its short term obligations.
  • KOVO has a worse Current ratio (0.07) than 77.78% of its industry peers.
  • KOVO has a Quick Ratio of 0.07. This is a bad value and indicates that KOVO is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of KOVO (0.07) is worse than 77.78% of its industry peers.
Industry RankSector Rank
Current Ratio 0.07
Quick Ratio 0.07
KOVO.CA Yearly Current Assets VS Current LiabilitesKOVO.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 58.03% over the past year.
  • KOVO shows a small growth in Revenue. In the last year, the Revenue has grown by 3.54%.
  • KOVO shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 21.39% yearly.
EPS 1Y (TTM)58.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2.9%
Revenue 1Y (TTM)3.54%
Revenue growth 3Y21.39%
Revenue growth 5YN/A
Sales Q2Q%3.48%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
KOVO.CA Yearly Revenue VS EstimatesKOVO.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for KOVO. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
KOVO.CA Price Earnings VS Forward Price EarningsKOVO.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
KOVO.CA Per share dataKOVO.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05 -0.1 -0.15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for KOVO!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

KOVO+ HOLDINGS INC

TSX-V:KOVO (2/18/2026, 7:00:00 PM)

0.025

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-28
Earnings (Next)04-28
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners73.89%
Ins Owner ChangeN/A
Market Cap4.42M
Revenue(TTM)10.81M
Net Income(TTM)-6.36M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.3
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.05
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0.08
BVpS-0.06
TBVpS-0.16
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -43.18%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-35.27%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0.29%
Cap/Sales 0.03%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.07
Quick Ratio 0.07
Altman-Z -3.2
F-Score3
WACC6.15%
ROIC/WACCN/A
Cap/Depr(3y)41.45%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.97%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)58.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2.9%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)3.54%
Revenue growth 3Y21.39%
Revenue growth 5YN/A
Sales Q2Q%3.48%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y13.97%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-259.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-455.65%
OCF growth 3YN/A
OCF growth 5YN/A

KOVO+ HOLDINGS INC / KOVO.CA FAQ

Can you provide the ChartMill fundamental rating for KOVO+ HOLDINGS INC?

ChartMill assigns a fundamental rating of 1 / 10 to KOVO.CA.


What is the valuation status of KOVO+ HOLDINGS INC (KOVO.CA) stock?

ChartMill assigns a valuation rating of 0 / 10 to KOVO+ HOLDINGS INC (KOVO.CA). This can be considered as Overvalued.


Can you provide the profitability details for KOVO+ HOLDINGS INC?

KOVO+ HOLDINGS INC (KOVO.CA) has a profitability rating of 1 / 10.


How financially healthy is KOVO+ HOLDINGS INC?

The financial health rating of KOVO+ HOLDINGS INC (KOVO.CA) is 0 / 10.